SCHEMBL4900237

SCHEMBL4900237

Cn1cnc2cc(Nc3c(NCc4cccc(O)c4)c(=O)c3=O)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.50
RAB9A P51151 9/20 0.50
GAA P10253 5/20 0.50
KDM4E B2RXH2 5/20 0.50
ALDH1A1 P00352 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
HSD17B10 Q99714 3/20 0.50
LMNA P02545 2/20 0.50
HTT P42858 2/20 0.50
HPGD P15428 2/20 0.50
ALOX15 P16050 2/20 0.50
GFER P55789 2/20 0.49
POLB P06746 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
MAPT P10636 4/20 0.47
TDP1 Q9NUW8 1/20 0.47
TP53 P04637 1/20 0.46
SHMT2 P34897 1/20 0.45
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902096 0.92 NOTUM (0.43) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL4906887 0.77 MAPKAPK2 (0.54) RAB9AGAAKDM4EALDH1A1LMNA
SCHEMBL4598968 0.77 RPS6KB1 (0.43) CHEK1DAPK3ROCK2CHEK2PRKACA
SCHEMBL4905587 0.77 ROCK1 (0.48) CHEK1DAPK3ROCK2CHEK2PRKACA
SCHEMBL4917069 0.75 EGFR (0.50) KDM4ELMNAALOX15KMT2AMAPT
SCHEMBL4908137 0.75 ROCK1 (0.52) CHEK1DAPK3ROCK2CHEK2PRKACA
SCHEMBL4597203 0.75 KMT2A (0.46) NPC1RAB9AALDH1A1SMN1; SMN2HSD17B10
SCHEMBL4597033 0.74 KDR (0.52) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL4596911 0.74 NAMPT (0.47) RAB9AMAPTTP53CHEK1DAPK3
SCHEMBL4916629 0.74 EGFR (0.49) KDM4ELMNAALOX15KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed
WO-2007014608-A1 QUADRATIC ACID II DERIVATIVES MERCK PATENT GMBH (DE) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 NPC1 4153/4885RAB9A 3176/4885GAA 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.